peptide vaccination
Sponsors
Toho University, Department of Surgical Oncology, Osaka City University Graduate School of Medicine, Kinki University School of Medicine Department of Surgery, Chiba Tokushukai Hospital, Sapporo Medical University
Conditions
Advanced esophageal squamous cell carcinoma refractory to standard therapeutic modalityHepatocellular carcinomabladder cancercholangiocarcinomapancreatic cancer
Phase 1
Phase I clinical study of peptide vaccine using Cancer-Testis antigen against advanced esophageal cancer
Active, not recruitingJPRN-UMIN000004006
Start: 2010-08-01Target: 5Updated: 2026-06-29
Pjase I study of peptide vacicination using eitope petide derived from novel oncoantigen for patients with metastatic or recuurent cholangiocarcinoma
Active, not recruitingJPRN-UMIN000004660
Start: 2010-01-01Target: 9Updated: 2026-06-29
Cancer Vaccine Therapy using Gene of antigen related to new cancer origin Epitope Peptide Restricted to HLA-A24 in Patients with Hepatocellular carcinoma(Phase 1/2 study).
RecruitingJPRN-UMIN000004664
Start: 2010-12-01Target: 30Updated: 2026-06-29
Cancer vaccine therapy using epitope peptide from KIF20A restricted to HLA-A*24 in patients with pancreatic cancer refractory to standard therapy (Phase I/II study)
Active, not recruitingJPRN-UMIN000004919
Start: 2009-03-01Target: 30Updated: 2026-06-29